This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magné, S.
Right arrow Articles by Dusanter-Fourt, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magné, S.
Right arrow Articles by Dusanter-Fourt, I.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 2003, p. 8934-8945, Vol. 23, No. 24
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.24.8934-8945.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

STAT5 and Oct-1 Form a Stable Complex That Modulates Cyclin D1 Expression

Sophie Magné, Sandrine Caron, Martine Charon, Marie-Christine Rouyez, and Isabelle Dusanter-Fourt*

Department of Hematology, Institut Cochin, INSERM U567, CNRS UMR 8104, Université René Descartes, 75014 Paris, France

Received 10 February 2003/ Returned for modification 7 April 2003/ Accepted 10 September 2003

Signal transducer and activator of transcription 5 (STAT5) is activated by numerous cytokines that control blood cell development. STAT5 was also shown to actively participate in leukemogenesis. Among the target genes involved in cell growth, STAT5 had been shown to activate cyclin D1 gene expression. We now show that thrombopoietin-dependent activation of the cyclin D1 promoter depends on the integrity of a new bipartite proximal element that specifically binds STAT5A and -B transcription factors. We demonstrate that the stable recruitment of STAT5 to this element in vitro requires the integrity of an adjacent octamer element that constitutively binds the ubiquitous POU homeodomain protein Oct-1. We observe that cytokine-activated STAT5 and Oct-1 form a unique complex with the cyclin D1 promoter sequence. We find that STAT5 interacts with Oct-1 in vivo, following activation by different cytokines in various cellular contexts. This interaction involves a small motif in the carboxy-terminal region of STAT5 which, remarkably, is similar to an Oct-1 POU-interacting motif present in two well-known partners of Oct-1, namely, OBF-1/Bob and SNAP190. Our data offer new insights into the transcriptional regulation of the key cell cycle regulator cyclin D1 and emphasize the active roles of both STAT5 and Oct-1 in this process.


* Corresponding author. Mailing address: Department of Hematology, Institut Cochin, INSERM U567, CNRS UMR 8104, Université René Descartes, 123 Blvd. Port-Royal, 75014 Paris, France. Phone: 33/1 53 10 43 54. Fax: 33/1 43 25 11 67. E-mail: dusanter{at}cochin.inserm.fr. {dagger}Contributed equally to this work.


Molecular and Cellular Biology, December 2003, p. 8934-8945, Vol. 23, No. 24
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.24.8934-8945.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Kang, J., Gemberling, M., Nakamura, M., Whitby, F. G., Handa, H., Fairbrother, W. G., Tantin, D. (2009). A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress. Genes Dev. 23: 208-222 [Abstract] [Full Text]  
  • Zhou, C., Tong, Y., Wawrowsky, K., Bannykh, S., Donangelo, I., Melmed, S. (2008). Oct-1 induces pituitary tumor transforming gene expression in endocrine tumors. Endocr Relat Cancer 15: 817-831 [Abstract] [Full Text]  
  • Tan, S.-H., Nevalainen, M. T (2008). Signal transducer and activator of transcription 5A/B in prostate and breast cancers. Endocr Relat Cancer 15: 367-390 [Abstract] [Full Text]  
  • Schisler, J. C., Fueger, P. T., Babu, D. A., Hohmeier, H. E., Tessem, J. S., Lu, D., Becker, T. C., Naziruddin, B., Levy, M., Mirmira, R. G., Newgard, C. B. (2008). Stimulation of Human and Rat Islet {beta}-Cell Proliferation with Retention of Function by the Homeodomain Transcription Factor Nkx6.1. Mol. Cell. Biol. 28: 3465-3476 [Abstract] [Full Text]  
  • Ogawa, S., Satake, M., Ikuta, K. (2008). Physical and Functional Interactions between STAT5 and Runx Transcription Factors. J Biochem 143: 695-709 [Abstract] [Full Text]  
  • Nam, S., Williams, A., Vultur, A., List, A., Bhalla, K., Smith, D., Lee, F. Y., Jove, R. (2007). Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells. Molecular Cancer Therapeutics 6: 1400-1405 [Abstract] [Full Text]  
  • Gardmo, C., Mode, A. (2006). In vivo transfection of rat liver discloses binding sites conveying GH-dependent and female-specific gene expression. J Mol Endocrinol 37: 433-441 [Abstract] [Full Text]  
  • Mesplede, T., Island, M.-L., Christeff, N., Petek, F., Doly, J., Navarro, S. (2005). The POU Transcription Factor Oct-1 Represses Virus-Induced Interferon A Gene Expression. Mol. Cell. Biol. 25: 8717-8731 [Abstract] [Full Text]  
  • Inman, C. K., Li, N., Shore, P. (2005). Oct-1 Counteracts Autoinhibition of Runx2 DNA Binding To Form a Novel Runx2/Oct-1 Complex on the Promoter of the Mammary Gland-Specific Gene {beta}-casein. Mol. Cell. Biol. 25: 3182-3193 [Abstract] [Full Text]  
  • Rouyez, M.-C., Lestingi, M., Charon, M., Fichelson, S., Buzyn, A., Dusanter-Fourt, I. (2005). IFN Regulatory Factor-2 Cooperates with STAT1 to Regulate Transporter Associated with Antigen Processing-1 Promoter Activity. J. Immunol. 174: 3948-3958 [Abstract] [Full Text]